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Centrosomes nucleate and organize interphase MTs and are instrumental in the assembly of the 
mitotic bipolar spindle. Here we report that two members of the multifunctional protein 4.1 
family have distinct distributions at centrosomes. Protein 4.1R localizes to mature centrioles 
whereas 4.1G is a component of the pericentriolar matrix surrounding centrioles. To selectively 
probe 4.1R function, we used RNA interference-mediated depletion of 4.1R without decreasing 
4.1G expression. 4.1R downregulation reduces MT anchoring and organization at interphase and 
impairs centrosome separation during prometaphase. Metaphase chromosomes fail to properly 
condense/align and spindle organization is aberrant. Notably 4.1R depletion causes 
mislocalization of its binding partner NuMA (Nuclear Mitotic Apparatus Protein), essential for 
spindle pole focusing, and disrupts ninein. During anaphase/telophase, 4.1R-depleted cells have 
lagging chromosomes and aberrant MT bridges. Our data provide functional evidence that 4.1R 
makes crucial contributions to centrosome integrity and to mitotic spindle structure enabling 
mitosis and anaphase to proceed with the coordinated precision required to avoid pathological 
events.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Centrosomes nucleate and organize interphase microtubules (MTs) and are instrumental in 
assembly of mitotic bipolar spindles responsible for accurate chromosome segregation. Precise 
distribution of duplicated chromosomes to daughter cells is of paramount importance since 
aberrant cell division is associated with genetic diseases and aneuploidy is characteristic of many 
cancers. To date the structural components of centrosomes and their functions are only partially 
characterized. The multifunctional structural protein 4.1 formerly was only categorized as a 
crucial red cell adaptor protein stabilizing spectrin-actin lattices and anchoring them to plasma 
membrane proteins. However, in nucleated cells protein 4.1 is newly recognized as an important 
structural component of centrosomes and mitotic spindle poles, as well as of the midbody and the 
nucleus (De Carcer et al., 1995; Delhommeau et al., 2002; Krauss et al., 1997b; Krauss et al., 
1997a; Mattagajasingh et al., 1999). 
As adaptor proteins integrating centrosomal components, 4.1 isoforms could be crucial 
for centrosomal functions such as mitotic spindle assembly, cytokinesis, and MT organization 
governing cell shape, polarity, motility and intracellular transport (Hinchcliffe and Sluder, 
2001a; Kellogg et al., 1994; Khodjakov and Rieder, 2001; Piel et al., 2001). Centrosomes consist 
of a cylindrical tubulin-rich centriole pair, the more mature centriole having “appendages” at its 
distal end appearing to anchor MTs (Mogensen et al., 2000). Proteins such as EB1, p150/glued, 
cenexin/ODF2 and centriolin differentiate mature from immature centrioles as well as distal 
appendage proteins, including ninein and ε-tubulin (Bornens, 2002; Chang et al., 2003; Gromley 
et al., 2003; Lange and Gull, 1995; Nakagawa et al., 2001). Surrounding centrioles is 
pericentriolar material (PCM) containing many protein complexes such as pericentrin scaffolds 
contacting γ-tubulin ring complexes (γ-TURCs) which nucleate MT growth (Dictenberg et al., 
1998; Moritz et al., 1995; Schnackenberg et al., 1998; Zheng et al., 1995). Proteins such as 
PCM-1 likely mediate MT anchoring via assembly of subsets of centrosomal proteins 
(Dammermann and Merdes, 2002). Centrosomes duplicate, separate and mature in stages that 
correlate with cell cycle progression. During G1, each centrosome contains a mature and an 
immature centriole. During S, each centriole spawns a procentriole such that by S/G2 
centrosomes contain two centriole pairs which separate to form the spindle poles during mitosis. 
Previously, we characterized protein 4.1 as a “core” component of mammalian centrosomes 
and present in basal bodies of murine, porcine and Xenopus sperm (Krauss et al., 1997b; Krauss 
et al., 2004). By confocal microscopy, we detected 4.1 colocalized with centriolar tubulin, in 
surrounding PCM and on fibers connecting centriolar pairs in mammalian cells. At high 
resolution whole mount EM, 4.1 has a polar distribution on centrioles and decorates fibrous 
structures extending into the PCM (Krauss et al., 1997b). Using a cell-free Xenopus egg extract 
system we showed by depletion/addback that 4.1 is essential for spindle, centrosome aster and 
self-assembled MT aster assembly. Furthermore, dominant negative 4.1 peptides impaired MT 
dynamics and organization (Krauss et al., 2004). Significantly, 4.1 has binding sites for MTs 
(Perez-Ferreiro et al., 2001), the spindle pole focusing protein Nuclear Mitotic Apparatus protein 
(NuMA) (Mattagajasingh et al., 1999), and CPAP (Centrosome Protein 4.1-Associated Protein 
(Hung et al., 2000), a regulator of MT dynamics. 
Recently a 4.1 gene family was discovered necessitating refinement in identifying common 
as well as unique functions of its members. The prototypical 4.1, now called 4.1R (red cell), is 
abundant both in erythroid tissues and non-erythroid cells, 4.1G is generally distributed (Parra et 
al., 1998a; Walensky et al., 1998), 4.1N is predominantly neuronal (Walensky et al., 1999); 4.1B 
is detected mostly in brain (Parra et al., 1998b; Yamakawa et al., 1999). The new genes have 
some conserved subdomains in common (Parra et al., 2004) as well as unique regions, raising the 
important question if they have unique, redundant or synergistic functions.  
We report here that both 4.1R and 4.1G localize to centrosomes but have different 
subcentrosomal distributions during the cell cycle. We establish that 4.1R is a mature centriole 
component and 4.1G is resident in the PCM. Furthermore, by abrogating 4.1R function using 
RNA interference (RNAi)-mediated depletion, we characterized a pleiotropic phenotype 
involving altered centrosomal structure, centrosomal and mitotic spindle dysfunction, and 
impaired anaphase demonstrating important roles of 4.1R in centrosomal structure and function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
Protein 4.1R preferentially localizes to mature  centrioles and 4.1G to PCM regions 
4.1R and 4.1G contain highly homologous spectrin-actin binding and C-terminal domains, two 
domains we reported as critical for MT organization and dynamics (Krauss et al, 2004; Fig. 1 A). 
Antibodies specific for 4.1R or 4.1G (Fig. S1 A) detected focal 4.1R and 4.1G 
immunofluorescent signals at centrosomes in various cultured mammalian cells. Using 
deconvolution analysis, in asynchronous cells, 4.1R and 4.1G epitopes possessed distinct 
labeling patterns with partial overlap within centrosomes: 4.1R localized to centrioles while 4.1G 
localizes to the surrounding PCM network (Fig. 1 B, a-e and Fig. S1 B).  
We next compared 4.1R distribution to several key centrosomal proteins. Significantly, 
4.1R frequently localized at one or two centrioles labeled by centrin staining in many cells (Fig. 
1 B, a, f) or at a subset of supernumerary centrioles in human osteosarcoma U2OS cells 
(unpublished data). Rotation of reconstructed deconvolved 3D images revealed 4.1R epitopes 
distributed along the centriole, forming a tube or sleeve around centrin (Fig. 1 B’).  Furthermore, 
4.1R colocalized extensively with ninein, a signature subdistal appendage protein of mature 
centrioles (Fig. 1B, g), and was surrounded by p150/glued epitopes, another mature centriole 
marker (Fig. 1B, h) and part of the dynein/dynactin MT motor complex (Quintyne et al., 1999; 
Quintyne and Schroer, 2002). By contrast, the 4.1G network partially overlapped and extended 
beyond pericentrin epitopes, a signature PCM protein (Fig. 1 B, c) (Dictenberg et al., 1998). 
Taken together our experiments define 4.1R as a component of mature centrioles whereas 4.1G 
is a PCM component.  
 
Distributions of centrosomal 4.1R and 4.1G during progression through interphase into 
prophase 
As a component of mature centrioles, 4.1R would be expected to associate with the 
second maturing centriole during completion of G2. To test this, we analyzed distributions of 
4.1R and 4.1G epitopes in synchronized diploid human fibroblasts using the MT anchoring 
protein ninein as a mature centriole marker. 4.1R co-localized with ninein at a single centriole in 
a ring-shaped distribution in G1, began to extend to a second ninein-labeled maturing centriole 
during S phase (“one and a half rings”) and colocalized with ninein at both mature centrioles 
(two ring pattern) during G2 (Fig. 1 C). By contrast, 4.1G epitopes were distributed around 
ninein-marked mature centrioles in a lattice-like pattern in G1, S and G2. Therefore, while 4.1R 
accumulates at centrioles as they mature, 4.1G epitopes are detected in the PCM regardless of 
cell cycle stage. These data suggest that 4.1R functions at mature centrioles while 4.1G has 
functional interactions within surrounding PCM regions.  
 
4.1R RNAi affects MT organization during interphase  
Because 4.1R localized at mature and newly maturing centrioles, we reasoned that centriole 
morphogenesis and MT organization would be affected in cells depleted of 4.1R induced by 4.1R 
RNAi. To test this, we surveyed 4.1 family members expressed in various cultured mammalian 
cells using gene-specific antibodies to identify cells expressing only 4.1R. No cell line tested 
expressed exclusively 4.1R. However, CaSki cells and human diploid fibroblasts contained only 
4.1R and 4.1G, a combination that therefore must be sufficient for cell division. HeLa cells 
additionally contain a minor amount of 4.1N (Fig. S1 C).  
After transfection with a mixture of three RNA duplexes targeting 4.1R mRNA, Western 
blot analysis of a time course showed that 4.1R expression was significantly depleted (70-85%, 
Fig. 2 A) at 72-120 h.  No effects on protein levels were detected at 24 hours and only partial 
inhibition (~50%) was evident at 48 h (unpublished data). Silencing was specific for 4.1R 
expression since 4.1G expression did not decline relative to controls (Fig. 2 A). Transfection 
with individual RNAi duplexes showed similar 4.1R-specific depletion. A fourth control duplex 
with a variant sequence or mock transfection (Lipofectamine without duplex) did not affect 4.1R 
expression.  
Using CaSki or HeLa cells, we specifically downregulated 4.1R expression and 
immunostained asynchronous 4.1R RNAi-treated cells. Tubulin staining revealed 31% of 4.1R-
depleted cells with disorganized whorls of cytoplasmic MTs, in contrast to well-organized radial 
arrays in 98% of controls (Fig.  2 B, B’). We also observed 26% of 4.1R RNAi-treated cells with 
abnormally dispersed ninein relative to its characteristic circumscribed distribution in 97% of 
controls, whereas γ-tubulin localization was not affected (Fig. 2 C, C’). 
 MT anchorage and radial organization depends on many proteins including ninein, EB1, 
PCM-1, katanin, p150, CEP135 and MIRI. MT nucleation may be a distinct process occurring 
mainly in the PCM at γ-TURCs, while anchorage is at mature centriolar subdistal appendages 
and in the PCM. We tested if MT nucleation and/or regrowth were impaired by 4.1R RNAi 
treatment. Following MT depolymerization by cold and nocodazole exposure/washout, for 0-20 
min we found no detectable differences in MT nucleation and regrowth between control and 
4.1R RNAi treated cells even when ninein distribution was abnormal (Fig. 2 D, top). However, at 
25 min we observed asters in 4.1R RNAi treated cells in which radial MTs were distinctly 
separated from a centrin-stained centrosome (Fig. 2 D, middle), some even whorled. At longer 
times there was an increased frequency of MT disorganization and MTs not emanating from a 
focus of either centrin or perturbed ninein (Fig. 2 D, bottom and 2 D’). Since localization of γ-
tubulin, the defining member of the γ-TURC complex, was not perturbed (Fig. 2 C), we 
speculate that abrogating 4.1R expression may perturb ninein’s anchoring but not γ-tubulin MT 
nucleating functions. In fact, mutations in ninein cause MT anchoring defects without perturbing 
γ-TURC localization (Delgehyr et al., 2005). Interestingly, overexpression of a variant 4.1R 
isoform also does not impair MT nucleation/regrowth (Perez-Ferreiro et al., 2004). Future 
experiments will test direct interactions of 4.1R with ninein as well as with other mature 
centriole MT anchoring proteins.  
 
4.1R RNAi affects ninein recruitment to maturing centrioles 
In addition to quantitating centrosomal ninein perturbation after 4.1R RNAi, we analyzed 4.1R-
depleted cells with normal ninein patterns.  Compared to controls, 4.1R RNAi treated 
populations had more cells with one and a half ninein rings (S phase) and lower amounts of cells 
with two ninein rings (G2), indicating that progression toward centriole maturation was altered 
(Fig. 3 A). In addition, in cells with two ninein rings, we quantitated those in which two 
centrosomes were separated versus juxtaposed. Normally in prophase, mature centrosomes 
separate and migrate around the nucleus as nuclear envelope breakdown proceeds, culminating 
in bipolar spindle pole formation. We observed that 4.1R RNAi treated cultures had a ~2.5 
increase in cells with two mature centrioles juxtaposed (Fig. 3 B). This result indicates that even 
when there are two centrosomes present, 4.1R downregulation impacts their capacity to 
efficiently separate in order to establish a bipolar spindle. 
We next asked if perturbed ninein prevents entry into metaphase. By immunostaining 
phosphohistone H3 (a mitosis marker), we observed 4.1R RNAi-treated cells in early and mid- 
prophase with irregular ninein patterns (Fig. 3 C). Therefore, an altered distribution of ninein 
does not prevent the G2/M transition although, after downregulation of 4.1R, cells have a slower 
growth rate than controls (Fig S2).  
 
Mitotic spindle defects in 4.1R RNAi treated cells  
We previously showed that 4.1 is critical for mitotic spindle assembly and maintenance in 
Xenopus egg extracts (Krauss et al., 2004) and set out to compare effects of silencing 4.1R in 
mammalian cells. Although defective spindle morphology was previously observed after 24-48 h 
of 4.1R silencing in 15-20% of HeLa cells, specificity for 4.1R downregulation relative to 4.1G 
was not tested nor was mislocalization of key spindle proteins assessed (Huang et al., 2004). By 
immunofluorescence we observed control mitotic cells possessed focused spindle poles capped 
by NuMA epitopes and bipolar MT arrays emanating toward a metaphase plate with regularly 
aligned kinetochores (stained by CREST antibody) (Fig. 4, top row). MT interaction with 
kinetochores is a prerequisite for correct chromosome alignment and segregation (Pinsky and 
Biggins, 2005). In contrast, 4.1R depletion resulted in mono-, bi- and multi-polar spindles with 
decondensed chromatin not organized at a midplane between poles and misaligned CREST 
staining (Fig. 4, bottom). Furthermore, spindle MTs were disorganized, with the 4.1 binding 
partner NuMA broadly distributed at unfocused poles and mislocalized at non-polar areas (Fig. 4 
A, center). Multipolar spindles in 4.1R RNAi-treated populations stained with tubulin or 
phosphohistone H3 had multiple foci of centrin and ninein instead of only two labeled polar 
areas (Fig. 4 A, B). Quantitation of 4.1R RNAi treated cells revealed a dramatic increase in 
mitotic abnormalities by 96 hours (68% abnormal spindles compared with 8% in controls, Fig. 4 
C). This spectrum of mitotic defects including MT disorganization, multipolarity and unaligned, 
poorly-condensed chromatin closely resembles those we observed in Xenopus egg extracts in 
which 4.1 was immunodepleted or functionally disrupted (Krauss et al., 2004). Clearly one major 
mechanism generating spindle defects during 4.1R depletion in either system is mislocalization 
of NuMA, a protein required for highly focused spindle poles (Gaglio et al., 1995; Merdes et al., 
2000). However, our data further indicate that prior to mitosis in intact cells, immature precursor 
centrosomes, insufficient centrosome separation (an effector of spindle bipolarity), decreased 
centrosome-anchored MTs, and decondensed chromatin may also contribute to mitotic spindle 
defects. 
  
Lagging chromosomes and cytokinesis defects are detected in 4.1R RNAi treated cells 
Since centriole maturation, separation, and properly organized spindles are prerequisites for 
proper cytokinesis, we predicted that 4.1R depletion might produce cytokinesis defects. Indeed, 
4.1R RNAi-treated anaphase cells often displayed lagging chromatin trapped between nascent 
daughters and inappropriately localized spindles (Fig. 5, top and middle panels). Furthermore, 
while control cells at cytokinesis were connected by short bundled tubulin bridges, 4.1R depleted 
cells had various cytokinesis defects including elongated tubulin connecting structures, wide 
intercellular bridges, broken bridges, and tubulin bridges contacting multiple cells (Fig. 5, lower 
panel). Anaphase defects were apparent in 35% of 4.1R RNAi treated cells. Chromosome 
missegregation, spindle dysmorphology, and improper bridge formation in 4.1R RNAi treated 
cells could mechanistically be a consequence of defective centriole structure causing poorly 
anchored MTs. Several reports document that centrosomal function and completion of 
cytokinesis are interrelated (Gromley et al., 2003; Hinchcliffe and Sluder, 2001b; Khodjakov and 
Rieder, 2001) and, more specifically, that the mature centriole moves to the intercellular bridge 
before the conclusion of cytokinesis (Piel et al., 2001).  
        In summary, two protein 4.1 family members with unique and highly homologous regions 
have distinct subcentrosomal localizations. 4.1R localizes on maturing centrioles during cell 
cycle progression whereas 4.1G localizes in the surrounding PCM.  Do 4.1R and 4.1G have 
separable, redundant or synergistic functions? Coupled with ongoing identification of binding 
partners, we addressed this question initially by silencing 4.1R alone in cultured cells. This 
produced a complex phenotype affecting mitotic spindle MT and chromatin organization, 
centrosome functions, and interphase MT organization as well nuclear defects (unpublished 
data).  This spectrum of pleiotropic defects is strongly predictive of inaccurate chromosome 
segregation and likely reflects a loss of 4.1R acting as an adaptor protein within several 
integrated molecular networks responsible for spindle bipolarity, chromosome alignment and 
completion of cytokinesis. Protein 4.1 at centrosomes or even elsewhere may be key for 
assembly of critical centrosomal proteins responsible for centrosome maturation, separation and 
transition to spindle poles. This model is supported by reports of similar phenotypes often 
inactivating individual centrosome/spindle proteins. As a molecular linker, 4.1R interactions 
with NuMA, CPAP and potentially ninein and/or other MT anchoring proteins may in turn 
modulate MT attachment to kinetochores leading to defective chromosome 
condensation/alignment and cytokinesis. Our investigations highlight roles of the 4.1R and 4.1G 
multifunctional structural proteins in ensuring the integrity of cell division and suggest that loss 
or decrements in 4.1R function may lead to as yet unrecognized pathological consequences. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and methods 
 
Cells and media 
WI38, CaSki and HeLa cells were obtained from American Type Culture collection. WI38 and 
HeLa were cultured in DME-H21 media (Gibco BRL) and CaSki in RMPI 1640 (Cell Gro) as 
described previously (Krauss et al., 1997a). WI38 cells were synchronized by double thymidine 
block for 16-18 hours with 2mM thymidine.  
Immunofluorescence 
Cells grown on coverslips were fixed and stained by indirect immunofluorescence as described 
previously (Krauss et al., 1997a). Affinity purified rabbit antibodies against 4.1R were as 
described previously (Krauss et al., 1997a; Ramez et al., 2003), anti-centrin (20H5)  and GFP-
centrin were the kind gifts of J. Salisbury (Mayo Clinic Foundation, Rochester MN), mouse anti-
ninein was provided by G. Chan (Alberta Cancer Board, Alberta, Canada) and CREST serum 
was from A. von Hooser (UC-Berkeley, Berkeley CA). Chicken anti-4.1G was raised against a 
6XHis peptide encoding the U1 region of human 4.1G (EP41L2) containing 217 amino acids 
following the AUG1 start site (Parra et al., 1998a). Affinity purified immune IgY was analyzed 
to confirm no cross-reaction with recombinant 4.1R, 4.1B, 4.1N or with RBC 80kD 4.1R or an 
irrelevant 6Xhis peptide. Commercial antibodies were: rat anti-tubulin YL1/2 (Accurate 
Chemical and Scientific Corporation), monoclonal GTU88 against γ-tubulin (Sigma), rabbit anti-
pericentrin (Covance), monoclonal anti-p150 (BD Transduction Labs) and rabbit anti-
phosphohistone 3 (Upstate). Secondary antibodies with minimal species cross-reactivity were 
from Molecular Probes or Jackson ImmunoResearch. Parallel samples probed with equal 
amounts of control non-immune IgG/IgY or without primary antibody showed no fluorescent 
patterns under conditions used for experimental samples.  Images were acquired with a Nikon 
Eclipse 2000 using a 60x1.4 NA objective equipped with a Retiga Ex camera and ImagePro or a 
Deltavision microscope on an Olympus IX70 platform with a 100x1.35 NA objective.  Images 
were processed using Adobe Photoshop and volume rendering using Volocity.  
4.1R RNAi transfection 
Small interfering RNAs against human 4.1R from Dharmacon were: Duplex 1, 
GAAAGUCUGUGUAGAACAUUU; Duplex 2, UGACACAGUUUAUGAAUGUUU; 
Duplex 3, GGAUCCAAAUUUCGAUACAUU. Each duplex alone as well as a pool of all three 
specifically downregulated 4.1R expression. Control cells were transfected with duplex 
GCUAAGAAAUUAUGGAAAGUU, or with Lipofectamine 2000 alone. Each 35mm well 
containing 2x105 cells was transfected with 100nM RNA duplex complexed to Lipofectamine 
2000 as per manufacturer’s instructions. Downregulation of 4.1R expression by siRNA was 
detected beginning at 48 hours and was maximal 72-120 hrs. Cells were trypsinized and counted 
to determine relative growth rates.  
MT regrowth 
siRNA-transfected and controls cells were incubated for 30 min at 40C and then with 33μM 
nocodazole for 30 min at 370C to completely dissociate MTs. After washing out nocodazole with 
fresh media, cells were incubated for 2, 5, 10, 15, and 20 min and 2 h at 370C, washed in PBS, 
pH7.4, containing 2.7 mM KCl, 1.5 mM KH2PO4, 1mM MgCl2, 1 mM EGTA, 137 mM NaCl 
and 8.1 mM NaHPO4 and fixed in cold methanol for immunostaining. 
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Figure Legends 
Figure 1 Protein 4.1R epitopes are at mature centrioles and 4.1G is distributed in the PCM. 
(A) Schematic map of 4.1R and 4.1G with 3 unique regions (“U”) and 3 homologous domains: 
membrane-binding 30-kD/FERM domain, spectrin/actin binding domain (SAB) and C-terminal 
domain (CTD). Numbers below, degree of homology. Arrows, translation initiation sites. (B) 
Deconvolution sections of WI38 human fibroblast centrosomes stained for indicated proteins. 
For 3 colors, cells were transiently transfected with a fluorescent centrin fusion protein. Similar 
results were obtained using HeLa and CaSki cells. (B’) Rotation analysis of deconvolved 
sections of 4.1R/centrin recombined in a 3D rendering. 4.1R surrounds centrin signals of one 
centriole. (C) 4.1R and 4.1G distribution during cell cycle progression in human fibroblasts 
synchronized by double thymidine block. 4.1R localizes exclusively to centrioles also containing 
ninein while 4.1G is in the surrounding PCM area. Similar results were obtained using HeLa and 
CaSki cells. B(a-e), C, bar=0.5μ. B(f-h): 2X magnification 
 
Figure 2 After downregulation of 4.1R expression, ninein is perturbed and MTs become 
disorganized. (A) Representative Western blot of 4.1R and 4.1G at 96 h after 4.1R RNAi. 4.1R 
expression decreased 70-85% in HeLa cells and ~65% in CaSki cells when normalized to actin 
while 4.1G expression was not markedly altered. (B) Immunofluorescent staining of tubulin and 
4.1R. In 4.1R RNAi-treated cells with no detectable 4.1R signals over background, MTs appear 
whorled in contrast to controls with MTs radiating from a focal point (arrow). Bar=10μ. (B’) 
Quantitation of perturbed tubulin. 4.1R RNAi treated CaSki cells, n=1339; controls, n=1016 (3 
independent experiments. Similar results in HeLa). (C) Abnormal ninein distribution at 
centrioles in 4.1R depleted cells. Immunostaining is irregular, dispersed, larger or smaller 
relative to single or double circular patterns in controls. γ-Tubulin distribution is not affected. 
(C’) Quantitation of perturbed ninein. 4.1R RNAi, n=803; controls, n=607 (3 independent 
experiments in CaSki cells. Similar results in HeLa). Bar=1μ (D) MT nucleation at 370 C in 4.1R 
RNAi-treated cells and controls is similar up to 20 min after nocodazole exposure/washout. 
Subsequently MTs in 4.1R RNAi-treated cells become distanced from centrioles (25 min) and 
disorganized (2h). Centrioles imaged with anti-centrin or anti-ninein (enlarged insets). DNA, 
DAPI. (D’) Quantitation of decreased focused MT radial arrays (300 HeLa cells per time point). 
Additional experiments, at 200 C and in CaSki cells, also showed regrowth unaffected in 4.1R 
depleted cells relative to controls but MTs subsequently became disarrayed. Bar=3μ. 
 
Figure 3 Downregulation of 4.1R expression affects ninein distribution at maturing 
centrioles and centrosome separation. Centrioles were scored by ninein immunostaining after 
96 h 4.1R RNAi treatment. (A) 4.1R RNAi-treated CaSki cells with apparently normal ninein 
patterns show similar amounts of G1 cells (1 circle) as controls but more cells with ninein S 
phase staining (1.5 circles) and less with G2 patterns (2 circles). Error bars are from 3 
experiments where 2.9% controls and 28% RNAi-treated cells had abnormal ninein staining. 
Control, n=442; RNAi, n=462. Asterisk, p=<0.05 (B) Cells exposed to 4.1R RNAi had 6.9% 
cells versus 21% controls with separated ninein-stained centrosomes. (C) Cells with perturbed 
ninein after 4.1R depletion can enter metaphase as marked by phosphohistone H3. DNA, DAPI.  
Left, early prophase and prophase control cells with circular ninein staining at each mature 
centriole. Right, 4.1R RNAi treated cells in early prophase and prophase having perturbed ninein 
(insets, ninein). Bar=1μ 
 
Figure 4 Mitotic abnormalities after 4.1R RNAi. (A) Mitotic cells with downregulated 4.1R 
expression (lower panels) have decondensed chromatin (DAPI), unaligned CREST staining 
(kinetochores) and mislocalized NuMA. Tubulin staining reveals multi- and mono-polar cells 
and centrin staining marks multiple poles. Bar=5μ. (B) Anti-phosphohistone 3 staining of a 
multipolar cell after 4.1R RNAi depletion shows multiple irregularly sized ninein foci and 
decondensed DNA in contrast to bipolar mitotic controls. (C) Quantitation of increased abnormal 
mitosis after 4.1R depletion in 3 experiments. Control, n=222; 4.1R RNAi, n=212. 
 
Figure 5 Anaphase/telophase defects after 4.1R RNAi (A) Anaphase cells with lagging 
chromosomes (right top panel, arrows), decondensed chromatin with dispersed CREST staining 
and misaligned spindles (tubulin, middle panel, right) relative to controls (left). In lower right 
panel, abnormal tubulin bridges formed at cytokinesis in 4.1R RNAi treated cells including 
broken, tricellular and elongated bridges. (B) Quantitation of anaphase defects. 4.1R RNAi, 
n=300; controls, n=264. DNA, DAPI. Bar=10μ. 
 
Figure S1 1 (A) Western blots of recombinant 4.1 proteins probed with affinity purified 4.1R, G, 
and N gene-specific antibodies. Anti-4.1B specificity has been previously tested (Ramez et al., 
2003). (B) Protein 4.1 family members present in cultured mammalian cell lines. Whole cell 
lysates were probed by Western blot with 4.1 gene-specific antibodies.  Human and murine 
fibroblasts as well as CaSki cells express only 4.1R and 4.1G. (C) Staining of CaSki cell with 
anti-4.1G showing centrosomal and cytoplasmic staining. Nuclear focal planes showed punctate 
4.1G staining. Centrosomal staining with anti-4.1R has been previously reported (Krauss et al., 
1997b). 
 
Figure S2 
Growth of CaSki and HeLa cells after exposure to 4.1R RNAi relative to control cultures. At the 
times indicated, cells were trypsinized and counted.  
 
 
 
 
 







